Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Logo for Transform Dementia

Congratulations to Postdoctoral Research Associate, Michele Veldsman, who has received a grant from the Race Against Dementia Seed Fund. The grant will fund the first year pilot of the initiative, Transform Dementia Research (TDR), a new non-profit social enterprise that aims to transform how dementia research is carried out and accelerate discovery.

The cross-disciplinary and industry team behind TDR – co-led by Michele Veldsman and Hugo Fernandes (University of Cambridge) – is made up of neuroscientists from the University of Oxford, the University of Cambridge, the University of Exeter and a former Formula 1 engineer. They have come together to radically revolutionise the way dementia research is done, taking inspiration from the speed of innovation, problem-solving and teamwork in Formula 1.

Michele Veldsman said: I am excited to co-lead Transform Dementia Research, which is aiming to completely change how we do dementia research. We want to find the biggest questions that need to be answered to accelerate discovery, then build cross-discipline, cross-industry teams to tackle these questions. We are taking inspiration from Formula 1, where teams work towards a single goal, innovating at incredible speed. We will encourage rigorous, innovative and open collaboration to bring real impacts to patients’ lives.

 

Race Against Dementia is a charity founded by F1 legend Sir Jackie Stewart.

Find out more.

Similar stories

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

COVID-19 infection has greater risk than vaccines of causing very rare neurological events

Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.